Fatal granulomatous meningoencephalitis associated to mycobacterium mucogenicum-like microorganism: a case report.
Abstract: Mycobacterium mucogenicum is rarely associated to human infections. However, in the last year, a few reports of sepsis and fatal cases of central nervous systems have been documented. Here we report a fatal case of granulomatous meningoencephalitis of three weeks of evolution where DNA from a M. mucogenicum-like microorganism was identified postmortem in samples of brain tissue.

Keywords: M. mucogenicum, CNS, immunocompetent, Meningoencephalitis

Desde los comienzos de los anos 80 se ha reportado un incremento en las enfermedades causadas por micobacterias no-tuberculosas (MNT) y otras micobacterias distintas a M. leprae. Mycobacterium mucogenicum es una micobacteria ambiental que se encuentra fundamentalmente en los suelos y aguas alrededor del mundo. Hasta su identificacion como un grupo taxonomico independiente, fue clasificado como microorganismo relacionado al Mycobacterium chelonae. Su primera asociacion con una enfermedad en humanos fue en 1982, Estados Unidos, donde se identifico como agente causal en dos brotes de peritonitis durante dialisis peritoneal. Reportes mas reciente han encontrado este agente en pacientes inmunocompetentes. En un caso de infecciones multiples en una paciente con sindrome de Miinchausen, probablemente debido a lesiones auto inflingidas t aunque manifestaciones del sistema nerviosos central han sido asociada solo en raras ocasiones al Mycobacterium mucogenicum, al menos dos casos de fatales se han reportado tambien en pacientes inmunocompetentes. Uno de meningitis linfocitica y otro con una tromboflebitis cerebral. Entre las tecnicas moleculares utilizadas para identificar a las MNT se encuentran la reaccion en cadena de la polimerasa, el analisis de fragmentos de restriccion y la reconstruccion filogenetica. El segmento geonomico mas utilizado, por presentar el mayor por ciento de heterogeneidad dentro de los aislados de M. mucogenicum y M. abscessus, es el correspondiente a la subunidad [beta] de la RNA polymerasa (gen rpo [beta]). En este trabajo, aplicando estas tecnicas, nosotros describimos un caso de meningoencefalitis granulomatosa con un desenlace fatal en tres semanas asociado a la deteccion de ADN de un microorganismo relacionado al M. mucogenicum en muestras de tejido cerebral tomadas post-mortem.
Subject: Meningitis (Investigacion cientifica)
Meningitis (Analisis de casos)
Meningitis (Diagnostico)
Sarcoidiosis (Investigacion cientifica)
Sarcoidiosis (Analisis de casos)
Sarcoidiosis (Diagnostico)
Biologia molecular (Historia)
Biologia molecular (Analisis de casos)
Authors: Sariol, Carlos A.
Galib, Yussef
Pantoja, Petraleigh
Colon, Lillian
Gonzalez, Anarda
Tormos, Lee Marie
Santana, Jorge
Luciano, Carlos A.
Gonzalez-Martinez, Janis
Kraiselburd, Edmundo N.
Pub Date: 09/01/2009
Publication: Name: Puerto Rico Health Sciences Journal Publisher: Universidad de Puerto Rico, Recinto de Ciencias Medicas Language: Spanish Audience: Academic Format: Magazine/Journal Subject: Health Copyright: COPYRIGHT 2009 Universidad de Puerto Rico, Recinto de Ciencias Medicas ISSN: 0738-0658
Issue: Date: Sept, 2009 Source Volume: 28 Source Issue: 3
Geographic: Geographic Name: Puerto Rico
Accession Number: 206864575
Full Text: Since the early 1980's there has been an increase in diseases caused by nontuberculous mycobacteria (NTM); mycobacteria other than Mycobacterium tuberculosis and M. leprae. Mycobacterium mucogenicum is a common environmental mycobacterium found in water and soil with a worldwide distribution. Until its identification as a new taxon, it was known as Mycobacterium chelonac-like organisms (1). It was first identified as causing diseases in humans in 1982, during two outbreaks of peritonitis associated with peritoneal dialysis in the United States (2). Recent reports have identified this mycobacterium in immunocompetent patients. Multiple infections were described in a patient with the diagnosis of Munchausen syndrome most likely due to self-inoculations (3). The Central Nervous System is rarely involved in M. mucogenicum symptoms, however, two unrelated fatal cases, one of lymphocytic meningitis and other of a cerebral thrombophlebitis in immunocompetent patients have been described (4). Molecular techniques to identify NTM include nucleotide amplification followed by restriction fragment length polymorphism (RFLP) or phylogenctic reconstructions. The B subunit of RNA polymerase (rpoB gene) (nucleotide sequence 2573 to 3337) showed the highest genetic heterogeneity within the clinical isolates of M. mucogenicum and M. abscessus (5-6).

Case Report

Case of a 42 year-old male who presented himself at the emergency room on Day 0 with history of headache, fever, chills, dizziness, myalgias and prostration of three weeks duration. In the previous three weeks he sought ambulatory treatment and was treated with analgesics for the headaches. On the day of admission he complained of fever, headache, blurred vision and feeling ataxic. Physical examination was remarkable for neck tenderness. Babinski, Brudzinski and Kernig signs were negative. He also brought results of a head CT scan performed five days before which revealed changes suggestive of old lacunar infarcts and a hypodense cystic area on posterior aspect of right internal capsule. He was admitted with a diagnostic (vs. clinical) impression of meningoencephalitis. On day 1, neurologist noted mild sixth cranial nerve palsy. There was no photophobia. Spinal tap revealed clear yellow fluid with increased protein 457 (15-45 mg/dL), reduced glucose 27 (40-80 mg/dL), diminished chloride 109 (119-129 meq/l), increased RBC's 140.8 (0-2 cmm), and leukocytosis with monocytic predominance 84%. That same day a brain MRI showed tiny areas of hyperintensity in basal ganglia and right frontal location but no evidence of encephalitis. Patient was started on Acyclovir, Ampicillin and Azithromycin IV. On day 2, serology and microbiology results were reported as negative. On day 3 Herpes B scrology (Cercopithecine herpesvirus 1) was ordered due to occupational exposure to non-human primates. That same day, spiking fevers were noted by attending physician. On day 4, the patient became disoriented with respect to time and place. On day 6, Babinski reflex was elicited. That same afternoon, patient's speech became unintelligible; he was unable to be fully aroused by painful stimuli and sixth nerve palsy worsened as per physical examination. A head CT scan revealed sudden dilatation of the lateral and third ventricles and patient was transferred to the Intensive Care Unit due to increased aggressiveness, disorientation, and abrupt onset of diplopia, blurred vision and vertigo. Because of an anecdotic report of exposure to Mycobacterium tuberculosis more than 14 years ago, he was also started on Isoniazid, Rifampin, Ethambutol, and Pyrazinamide. On day 7, full neurological examination disclosed no spontaneous respiration, no response to painful stimuli, no decerebrate nor decorticate posturing; fixed, dilated pupils unresponsive to light, no response to ice water irrigation, no corneal or gag reflexes and no deep tendon reflexes. An electroencephalogram was subsequently performed yielding an isoclectric line, a finding compatible with brain death. Patient's condition continued to deteriorate and death ensued on the ninth day after his admission.


Negative microbiology results included Herpes simplex PCR, Cryptococcus antigen, spinal fluid bacterial culture (Gram and Ziehl-Neelsen acid-fast staining), HIV 1 and 2 serology, blood culture, spinal fluid fungi culture, urine culture, anti-streptolysin O titer, VDRL-RPR and Cytomegalovirus IgG. Immunoglobulin quantification assays revealed low IgG and IgM values (595.00 mg/ dL and 60.5 mg/dL, respectively). A leukocytosis with neutrophilic predominance of 80.3-88 % was present in all complete blood counts.

At the autopsy the most significant findings were located in the brain, heart, lungs and liver. Examination of the heart revealed cardiomegaly, left ventricular hypertrophy, subendocardial necrosis, early fibrosis and increased lipofuscin pigment, consistent with hypertensive vascular disease despite negative history. Lungs were heavy and edematous but there was no evidence of pulmonary tuberculosis or granulomatous disease. Liver showed mild macrovacuolar steatosis, cholestasis and scattered areas of hepatic necrosis. Examination of the brain demonstrated extensive, diffuse lymphoplasmatic leptomeningeal infiltrates accompanied by multinucleated giant cells, non caseating granulomas and necrosis (Figure 1). There were perivascular inflammatory infiltrates with occasional hemosiderin laden macrophages extending into the Virchow-Robin spaces. There were microglial nodules present on the sections of the hippocampus, pons and medulla. No viral cytopathic changes were seen. Autopsy results were confirmed by the Armed Forces Institute of Pathology staff.


In order to conduct molecular biology studies, several parts of the brain were processed for DNA extraction. Samples were obtained both from paraffin embedded and formalin fixed samples. DNA was subject to PCR amplification for herpes B virus, amoebas and mycobacteria. This patient worked with non-human primates during 15 years as veterinary supervisor technician. Because of that, special emphasis was placed in the diagnosis of herpes B virus. Both serological and PCR studies were negative when tested in our Virology Laboratory and at the National Reference B virus Laboratory, Atlanta, GA. PCR for Acanthamoebas, Balamuthia and Naegleria were negative when tested in our laboratory (7-9). Stained slides were examined at the Division of Parasitic Diseases, National Center for Infectious Diseases, CDC, Atlanta GA, for Acanthamoebas, Balamuthia, Naegleria and Sappinia and structures compatible with these organisms were not found. Immunofluorescence conducted on unstained slides using anti-amoebic sera (Acanthamoebas, Balamutia and Naegleria) was also negative. Patient serum was tested for antibodies to Acanthamoebas and Balamuthia and titers (1:32 and 1:16 respectively) were not indicative of infection with these amoebas.

After amplifying DNA extracted from 35 different parts of the encephalon, a robust PCR band at the expected size (360 bp) was obtained from two samples representing the temporal brain lobe. To characterize the mycobacterium a RFLP was done essentially according to Lee, et al (10). The restriction pattern produces five Mspl bands (157, 95, 57, 45, 21 bp) and four Hae III bands (197, 107, 32, 63 bp) (results not shown). Because RFLP pattern from other M. mucogenicum strains were not available for comparison, nucleotide sequencing was performed to clarify the origin of this PCR band. The amplified sequence showed the maximal homology of 86% percent with M. mucogenicum (data not shown).

Then we amplified a region of the rpoB gene that has been used for phylogenetic reconstruction and identification of interspecies strains. For the first and the nested PCR we used the pair of primers MycoF and MycoR and MycosegF and MycoSegR respectively (5). The PCR was sequenced using internal vector primers on an ABI Prism 3100 Genetic Analyzer (Perkin-Elmer Applied Biosystem). The resulting sequence was aligned with available sequences in the GeneBank using the program Clustal W (11). Phylogenetic reconstruction was performed using the PHYLIP (version 3.66) software package (12). The amplified sequence from this case clustered with M mucogenicum sequences as defined by Neighbor joining (NJ) and Parsimony (PARS) methods with a 99.6% and a 73.7% of bootstrap values respectively (Figure 2).

Discussion and Conclusions

M. mucogenicum is considered a rapidly growing mycobacterium (RGM) and an environmental organism. However, like other species of this group it was initially isolated from a patient. In the present case, a potential contamination from tap water during the autopsy could be suggested as the original source of this agent. However, if that were the case, we could expect more than two positive tissue samples from those 35 tested. Additionally, the identification of this agent in tap or drinking water required a concentration process of 500 to 50 ml of water followed by subsequent bacterial cultures. (13-15). The count of nontuberculous mycobacteria in water samples have been determined to be 1 to 20 colonies in 500 ml (13). The running water from the autopsy room was only in contact with the encephalon surface while washing it. After that, water residues were displaced by the buffers used: embedding in paraffin or fixed by formalin. Since after this process, only few milligrams of formalin-fixed tissue or paraffin embedded tissues were used for the DNA extraction, it is unlikely we would get a positive PCR directly from the samples. In addition, the 1 ml water sample from the autopsy room used as control was negative.

The microorganism was not isolated because at the moment of the PCR identification, adequate samples for culture were not longer available. However, several facts support this microorganism as etiological agent. The clinical presentation of neurological symptoms without meningeal signs, as well as the fulminant evolution resemble the cases of the two previously reported patients (4). In addition, the cerebrospinal fluid profile of this patient is consistent with the presence of bacterial growth, while the negative standard bacterial culture supports the presence of an uncommon microorganism. The presence of a mycobacterium is reinforced by the exclusion of other potential agents like amoebas and the presence of a granulomatous reaction and a lymphoplasmacytic infiltrate in the brain sections.

There was no evidence of immunodeficiency in this patient. However, roommates reported daily alcohol intake for the last 14 years. Despite that, this person had no impaired social nor vocational functioning. It is known that the acute and chronic use of alcohol dampers the immune system. Impaired host defense after alcohol exposure appears to be linked to a combination of decreased inflammatory response, altered cytokine production, and abnormal reactive oxygen intermediate generation (16-17). The cellular immunity, which is essential for an effective immune response to intracellular pathogens like mycobacterium, is particularly affected (18).

The source of infection with this microorganism is quite difficult, if not impossible, to determine. Because of the generalized symptoms present and the febrile syndrome three weeks before the admission, it is unlikely that the infection was nosocomial.

In our opinion, after considering all circumstances including clinical presentation, the CSF profile of this patient, the anatomic-pathological findings and the phylogenetic reconstruction results, we conclude that a Mycobacterium mucogenicum-like organism is the most plausible causal agent involved in the clinical evolution (and subsequent demise) of this patient.

To our knowledge, this is the first report of a M. mucogenicum-related organism associated with a Granulomatous Meningoencephalitis.



We thank G. Visvesvara and his lab personnel for their excellent contribution in ruling out amoebic infection, Dr. B. Valladares for kindly providing amoebas DNAs, Dr. A. Osuna for his useful discussions and critical reading of this manuscript. We also want to thank Zoologix's staff for their useful technical advices which made possible this diagnosis; Ms. LB Rosdado for her technical contribution and Mr. R. Medina for his assistance. This work was supported by the NIH grants U42 RR 16021, U24 RR18108 and P40 RR03640. Partially funded by RCMI-UPR and MBRS-RISE UPR Programs. Authors have no conflict of interest.


(1.) Springer B, Bottger EC, Kirschner P, Wallace RJ Jr. Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov. Int J Syst Bacteriol 1995;45:262-267.

(2.) Band JD, Ward JI, Fraser DW, et al. Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis 1982;145:9-17.

(3.) Fonteyn N, Wauters G, Vandercam B, et al. Mycobacterium mucogenicum sepsis in an immunocompetent patient. J Infect 2006; 53:e 143-146.

(4.) Adekambi T, Foucault C, La Scola B, Drancourt M. Report of two fatal cases of Mycobacterium mucogenicum central nervous system infection in immunocompetent patients. J Clin Microbiol 2006;44:837-840.

(5.) Adekambi T, Colson P, Drancourt M. rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobactena. J Clin Microbiol 2003;41:5699-5708.

(6.) Adekambi T, Drancourt M. Dissection of phylogenetic relationships among 19 rapidly growing Mycobacterium species by 16S rRNA, hsp65, sodA, recA and rpoB gene sequencing. Int J Syst Evol Microbiol2004;54:2095-20105.

(7.) Schroeder JM, Booton GC, Hay J, et al. Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of acanthamoebae from humans with keratitis and from sewage sludge. J Clin Microbiol2001;39:1903-1911.

(8.) Schuster FL, Dunnebacke TH, Booton GC, et al. Environmental isolation of Balamuthia mandrillans associated with a case of amebic encephalitis. J Clin Microbiol 2003;41:3175-3180.

(9.) Yagi S, Booton GC, Visvesvara GS, Schuster FL. Detection of Balamuthia mitochondrial 16S rRNA gene DNA in clinical specimens by PCR. J Clin Microbiol2005;43:3192-317.

(10.) Lee H, Park HJ, Cho SN, Bai GH, Kim SJ. Species identification of mycobactena by PCR-restriction fragment length polymorphism ofthe rpoB gene. J Clin Microbiol 2000;38:2966-2971.

(11.) Chenna R, Sugawara H, Koike T, et al. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 2003;31:3497-3500.

(12.) Felsenstein J. PHYLIP-phylogeny inference package (version 3.2). Cladistics 1989;5:164-166.

(13.) Covert TC, Rodgers MR, Reyes AL, Stelma GN, Jr. Occurrence of nontuberculous mycobactena in environmental samples. Appl Environ Microbiol 1999;65:2492-2496.

(14.) Fleming GA, Frangoul H, Dermody TS, Halasa N. A cord blood transplant recipient with Mycobacterium mucogenicum central venous catheter infection after infusion of tap water. Pediatr Infect Dis J 2006;25:567-569.

(15.) Kline S, Cameron S, Streifel A, et al. An outbreak of bacteremias associated with Mycobacterium mucogenicum in a hospital water supply. Infect Control Hosp Epidemiol 2004;25:1042-1049.

(16.) Mandrekar P, Dolganiuc A, Bellerose G, et al. Acute alcohol inhibits the induction of nuclear regulatory factor kappa B activation through CD14/toll-like receptor 4, interleukin-1, and tumor necrosis factor receptors: a common mechanism independent of inhibitory kappa B alpha degradation? Alcohol Clin Exp Res 2002;26:1609-1614.

(17.) Szabo G. Consequences of alcohol consumption on host defence. Alcohol Alcohol 1999;34:830-841.

(18.) Szabo G, Chavan S, Mandrekar P, Catalano D. Acute alcohol consumption attenuates interleukin-8 (IL-8) and monocyte chemoattractant peptide-1 (MCP-1) induction in response to ex vivo stimulation. J Clin Immunol 1999;19:67-76.

CARLOS A. SARIOL, MD, MSC * ([dagger][double dagger]); YUSSEF GALIB, MD ([section]); PETRALEIGH PANTOJA, MT *; LILLIAN COLON, MD ([section]); ANARDA GONZALEZ, MD ([section]); LEE MARIE TORMOS, MD ([section]); JORGE SANTANA, MD ([double dagger]); CARLOS A. LUCIANO, MD ([paragraph]); JANIS GONZALEZ-MARTINEZ, Ph D *; EDMUNDO N. KRAISELBURD, Ph D * ([dagger])

* Unit of Comparative Medicine, Caribbean Primate Research Center, ([dagger]) Department of Microbiology and Medical Zoology, ([double dagger]) Department of Internal Medicine, ([section]) Department of Pathology and Laboratory Medicine, ([paragraph]) Specialized Neuroscience Research Program in NeuroAIDS, University of Puerto Rico-Medical Sciences Campus.

Address correspondence to: Dr. Carlos A. Sariol, Department of Microbiology, Main Building, third floor, office B-315, School of Medicine, Medical Sciences Campus, PO Box 365067, Rio Piedras, San Juan, PR 00936-5067. Tel: (787) 758-2525 ext 5112 * Fax: 787-767-1442 * Email: csariol@rcm.upr.edu
Gale Copyright: Copyright 2009 Gale, Cengage Learning. All rights reserved.